Literature DB >> 25001253

The pathophysiology, diagnosis and treatment of excessive belching symptoms.

Boudewijn F Kessing1, Albert J Bredenoord1, André J P M Smout1.   

Abstract

Excessive belching is a commonly observed complaint in clinical practice that can occur not only as an isolated symptom but also as a concomitant symptom in patients with gastroesophageal reflux disease (GERD) or functional dyspepsia. Impedance monitoring has revealed that there are two mechanisms through which belching can occur: the gastric belch and the supragastric belch. The gastric belch is the result of a vagally mediated reflex leading to relaxation of the lower esophageal sphincter and venting of gastric air. The supragastric belch is a behavioral peculiarity. During this type of belch, pharyngeal air is sucked or injected into the esophagus, after which it is immediately expulsed before it has reached the stomach. Patients who belch excessively invariably exhibit an increased incidence of supragastric, not of gastric belches. Moreover, supragastric belches can elicit regurgitation episodes in patients with the rumination syndrome and sometimes appear to induce reflux episodes as well. Behavioral therapy has been proven to decrease belching complaints in patients with isolated excessive belching, but its effect is unknown in frequently belching patients with GERD, functional dyspepsia or rumination.

Entities:  

Mesh:

Year:  2014        PMID: 25001253     DOI: 10.1038/ajg.2014.165

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  15 in total

1.  Belching, regurgitation, chest tightness and dyspnea: not gastroesophageal reflux disease but asthma.

Authors:  Jing-Xi Zhang; Xian-Bao Zhan; Chong Bai; Qiang Li
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

2.  Characterization and mechanisms of the supragastric belch in the cat.

Authors:  Ivan M Lang; Bidyut K Medda; Reza Shaker
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-06-15       Impact factor: 4.052

Review 3.  High-resolution esophageal manometry: interpretation in clinical practice.

Authors:  Rena Yadlapati
Journal:  Curr Opin Gastroenterol       Date:  2017-07       Impact factor: 3.287

4.  Anesthesia for a Patient With Excessive Supragastric Belching.

Authors:  Michelle Wong
Journal:  Anesth Prog       Date:  2017

5.  Postprandial High-Resolution Impedance Manometry Identifies Mechanisms of Nonresponse to Proton Pump Inhibitors.

Authors:  Rena Yadlapati; Michael Tye; Sabine Roman; Peter J Kahrilas; Katherine Ritter; John E Pandolfino
Journal:  Clin Gastroenterol Hepatol       Date:  2017-09-12       Impact factor: 11.382

6.  Speech Therapy as Treatment for Supragastric Belching.

Authors:  Liesbeth Ten Cate; Thomas V K Herregods; Philippe H Dejonckere; Gerrit J M Hemmink; André J P M Smout; Albert J Bredenoord
Journal:  Dysphagia       Date:  2018-03-24       Impact factor: 3.438

Review 7.  Chronic Burping and Belching.

Authors:  M Zad; A J Bredenoord
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-23

Review 8.  Patients with refractory reflux symptoms: What do they have and how should they be managed?

Authors:  P J Kahrilas; L Keefer; J E Pandolfino
Journal:  Neurogastroenterol Motil       Date:  2015-09       Impact factor: 3.598

9.  Diagnostic yield and reliability of post-prandial high-resolution manometry and impedance-ph for detecting rumination and supragastric belching in PPI non-responders.

Authors:  Kelli DeLay; John E Pandolfino; Sabine Roman; C Prakash Gyawali; Edoardo Savarino; Michael Tye; Alexander Kaizer; Rena Yadlapati
Journal:  Neurogastroenterol Motil       Date:  2021-03-09       Impact factor: 3.960

10.  Efficacy of Weikang Pian in Patients with Functional Dyspepsia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.

Authors:  Lijing Yan; Lijin Yu; Linlin Zhao; Dongsheng Wang; Dilan Qin; Haiwei Fan; Ling Cheng; Musen Qiu; Xiao Chen; Lu Zhou; Juan Qiu; Jiamei Yao; Wenbo Wang; Xinjian Qiu
Journal:  Evid Based Complement Alternat Med       Date:  2019-11-06       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.